Leptomeningeal metastasis is a rare but serious complication to cancer, with a grave prognosis. No efficient treatment exists. Recent data suggest that craniospinal radiotherapy lead to superior survival and CNS control compared to focal photon radiotherapy. We want to offer Danish patients the new treatment, but within a protocol, as this is new data with an new treatment principle
Patients must be referred from Danish Departments of Oncology with radiotherapy service. Patients with leptomeningeal metastasis from both solid and hematological cancers will be offered proton radiotherapy with 30 Gy in 10 fractions to the entire craniospinal axis. Patients will be followed with registration of side effects, neurology and MRI scans every 3 months until 1 year.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
50
30 Gy in 10 fractions to CNS
Aarhus University Hospital
Aarhus, Aarhus, Denmark
RECRUITINGDepartment of Oncology, Aalborg University Hospital
Aalborg, Denmark
RECRUITINGCNS control
local control
Time frame: 6 months
overall survival
actuarial
Time frame: 1 year
CNS-PFS dependent on tumor site
progression free survival, actuarial
Time frame: 1 year
Symptomatology
New symptoms, CTC AE 5.0 grade \>=3
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.